Synopsis of recent research by authors named "Andres Llano"
- Andres Llano's research primarily focuses on the effectiveness and cost-effectiveness of treatments for non-muscle-invasive bladder cancer (NMIBC), particularly evaluating the efficacy of different BCG strains and office-based fulguration techniques.
- In his comprehensive review, "Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains?", Llano highlights the lack of evidence distinguishing the clinical effectiveness of various BCG strains in treating CIS, while affirming their general effectiveness in preventing NMIBC recurrence and progression.
- His retrospective study on office fulguration of low-grade bladder cancer demonstrates that this procedure can be a viable alternative to traditional transurethral resection, offering potential long-term outcomes and cost savings, as assessed through cancer-specific mortality and disease progression metrics.
